drugset / Trial / NCT01159938

A Study of Postprandial Hyperglycemia in Participants With Type 2 Diabetes

NCT01159938 ↗

Phase 4 Completed 72 enrolled Eli Lilly and Company
RandomizedCrossoverOpen-label

Summary

This Study is looking at whether high blood glucose levels after a meal affect arterial stiffness more or less than low blood glucose levels, and whether certain cardiovascular markers influence the outcome of this.

Timeline

Start
2010-10
Primary completion
2013-02
Completion
2013-02

Outcome

Missed primary endpoint

registry p = 0.617; LS mean difference 0.26 (95% CI -0.78 to 1.30) NCT01159938 ↗

registry p = 0.676; LS Mean Difference -0.19 (95% CI -1.10 to 0.72) NCT01159938 ↗

registry p = 0.724; LS Mean Difference 0.20 (95% CI -0.94 to 1.34) NCT01159938 ↗

registry p = 0.466; LS Mean Difference -0.29 (95% CI -1.09 to 0.51) NCT01159938 ↗

registry p = 0.275; LS Mean Difference -0.48 (95% CI -1.36 to 0.40) NCT01159938 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Lispro Protein / enzyme biologic — Subcutaneous